These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Pre- and post-transplant anti-myosin and anti-heat shock protein antibodies and cardiac transplant outcome. Morgun A; Shulzhenko N; Unterkircher CS; Diniz RV; Pereira AB; Silva MS; Nishida SK; Almeida DR; Carvalho AC; Franco M; Souza MM; Gerbase-DeLima M J Heart Lung Transplant; 2004 Feb; 23(2):204-9. PubMed ID: 14761768 [TBL] [Abstract][Full Text] [Related]
5. Clinical implications of anti-heart autoantibodies in myocarditis and dilated cardiomyopathy. Caforio AL; Tona F; Bottaro S; Vinci A; Dequal G; Daliento L; Thiene G; Iliceto S Autoimmunity; 2008 Feb; 41(1):35-45. PubMed ID: 18176863 [TBL] [Abstract][Full Text] [Related]
6. Frequency and specificity of antiheart antibodies in patients with dilated cardiomyopathy detected using SDS-PAGE and western blotting. Latif N; Baker CS; Dunn MJ; Rose ML; Brady P; Yacoub MH J Am Coll Cardiol; 1993 Nov; 22(5):1378-84. PubMed ID: 7901255 [TBL] [Abstract][Full Text] [Related]
7. [Pathology of heart transplantation.(Morphological study of 1246 endomyocardial biopsies from 167 transplanted hearts). Causes of early, intermediate, and late deaths]. Agozzino L; Thomopoulos K; Esposito S; Agozzino M; De Vivo F; Maiello C; Cotrufo M Pathologica; 1999 Apr; 91(2):89-100. PubMed ID: 10484868 [TBL] [Abstract][Full Text] [Related]
9. Mixed cellular and humoral acute rejection in elective biopsies from heart transplant recipients. Zeglen S; Zakliczynski M; Wozniak-Grygiel E; Nozynski J; Laszewska A; Wojarski J; Wojnicz R; Przybylski R; Kucewicz-Czech E; Zembala M Transplant Proc; 2009 Oct; 41(8):3202-5. PubMed ID: 19857710 [TBL] [Abstract][Full Text] [Related]
10. [Autoantibodies against cardiac myosin in patients with myocarditis and dilated cardiomyopathy]. Lauer B; Padberg K; Schultheiss HP; Strauer BE Z Kardiol; 1995 Apr; 84(4):301-10. PubMed ID: 7785303 [TBL] [Abstract][Full Text] [Related]
11. Long-term benefits of immunoadsorption in β(1)-adrenoceptor autoantibody-positive transplant candidates with dilated cardiomyopathy. Dandel M; Wallukat G; Englert A; Lehmkuhl HB; Knosalla C; Hetzer R Eur J Heart Fail; 2012 Dec; 14(12):1374-88. PubMed ID: 22892122 [TBL] [Abstract][Full Text] [Related]
12. [Intramyocardial electrocardiogram (IMEG) in diagnosis of humoral rejection after heart transplantation]. Grauhan O; Müller J; Knosalla C; Pfitzmann R; Cohnert T; Siniawski H; Volk HD; Fietze E; Hetzer R Z Kardiol; 1996 Oct; 85(10):745-52. PubMed ID: 9036700 [TBL] [Abstract][Full Text] [Related]
13. Autoimmunity in myocarditis and dilated cardiomyopathy: cardiac autoantibody frequency and clinical correlates in a patient series from Italy. Caforio AL; Bauce B; Boffa GM; De Cian F; Angelini A; Melacini P; Razzolini R; Fasoli G; Chioin R; Schiaffino S; Thiene G; Dalla Volta S G Ital Cardiol; 1997 Feb; 27(2):106-12. PubMed ID: 9199945 [TBL] [Abstract][Full Text] [Related]
14. Human leukocyte antigen sensitization in ventricular assist device recipients: a lesser risk with the DeBakey axial pump. Grinda JM; Bricourt MO; Amrein C; Salvi S; Guillemain R; Francois A; Guibourt P; Deloche A; Fabiani JN Ann Thorac Surg; 2005 Sep; 80(3):945-8. PubMed ID: 16122460 [TBL] [Abstract][Full Text] [Related]
15. Soluble interleukin-2 receptor levels in patients with dilated cardiomyopathy. Correlation with disease severity and cardiac autoantibodies. Limas CJ; Goldenberg IF; Limas C Circulation; 1995 Feb; 91(3):631-4. PubMed ID: 7828286 [TBL] [Abstract][Full Text] [Related]
16. Cardiac autoantibodies in dilated cardiomyopathy become undetectable with disease progression. Caforio AL; Goldman JH; Baig MK; Haven AJ; Dalla Libera L; Keeling PJ; McKenna WJ Heart; 1997 Jan; 77(1):62-7. PubMed ID: 9038697 [TBL] [Abstract][Full Text] [Related]
17. Identification of alpha- and beta-cardiac myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy. Caforio AL; Grazzini M; Mann JM; Keeling PJ; Bottazzo GF; McKenna WJ; Schiaffino S Circulation; 1992 May; 85(5):1734-42. PubMed ID: 1533350 [TBL] [Abstract][Full Text] [Related]
18. Modulation of tissue-specific immune response to cardiac myosin can prolong survival of allogeneic heart transplants. Fedoseyeva EV; Kishimoto K; Rolls HK; Illigens BM; Dong VM; Valujskikh A; Heeger PS; Sayegh MH; Benichou G J Immunol; 2002 Aug; 169(3):1168-74. PubMed ID: 12133936 [TBL] [Abstract][Full Text] [Related]